|
|
Volumn 285, Issue 6, 2001, Pages 724-
|
|
From the Food and Drug Administration.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTICOAGULANT AGENT;
BOTULINUM TOXIN;
BOTULINUM TOXIN B;
DERMATOLOGICAL AGENT;
DRUG DERIVATIVE;
HIRUDIN DERIVATIVE;
HIRULOG;
IMMUNOSUPPRESSIVE AGENT;
MUSCLE RELAXANT AGENT;
PEPTIDE FRAGMENT;
RECOMBINANT PROTEIN;
TACROLIMUS;
ANTICOAGULANT THERAPY;
ARTICLE;
ATOPIC DERMATITIS;
ECZEMA;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
TORTICOLLIS;
TRANSLUMINAL CORONARY ANGIOPLASTY;
UNITED STATES;
UNSTABLE ANGINA PECTORIS;
ANGINA, UNSTABLE;
ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY;
ANTICOAGULANTS;
BOTULINUM TOXINS;
DERMATITIS, ATOPIC;
DERMATOLOGIC AGENTS;
ECZEMA;
HIRUDIN THERAPY;
HIRUDINS;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
NEUROMUSCULAR AGENTS;
PEPTIDE FRAGMENTS;
RECOMBINANT PROTEINS;
TACROLIMUS;
TORTICOLLIS;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
MLCS;
MLOWN;
|
|
EID: 0035857527
PISSN: 00987484
EISSN: None
Source Type: Journal
DOI: 10.1001/jama.285.6.724-jfd10001-3-1 Document Type: Article |
|
Times cited : (10)
|
|
References (0)
|
